Tygacil

Active Ingredient(s): Tigecycline
FDA Approved: * June 15, 2005
Pharm Company: * WYETH PHARMS INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tygacil Overview

Tigecycline is an antibiotic for a number of bacterial infections.[2][3] It is a glycylcycline administered intravenously. It was developed in response to the growing rate of antibiotic resistant bacteria such as Staphylococcus aureus, Acinetobacter baumannii, and E. coli.[2] As a tetracycline derivative antibiotic, its structural modifications has expanded its therapeutic activity to include Gram-positive and Gram-negative organisms, including...

Read more Tygacil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tigecycline

Recent Tygacil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tigecycline
  • Injection: 100mg, 10ml/50mg, 50mg, 50mg/vial
  • Powder: 50mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tygacil: (2 results)

Sorted by National Drug Code
  • 0008-4990 Tygacil 50 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc.
  • 0008-4994 Tygacil 50 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Wyeth Pharmaceuticals Inc., a Subsidiary of Pfizer Inc.

Other drugs which contain Tigecycline or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA